Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension

被引:4
作者
Simonson, Joseph L. [1 ]
Pandya, Dhwani [2 ]
Khan, Sarah [1 ]
Verma, Sameer [1 ]
Greenberg, Harly E. [1 ]
Talwar, Arunabh [1 ]
机构
[1] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Div Pulm Crit Care & Sleep Med, 410 Lakeville Rd,Suite 107, New Hyde Pk, NY 10040 USA
[2] Northwell Hlth Staten Isl Univ Hosp, Dept Med, 475 Seaview Ave, Staten Isl, NY 10305 USA
关键词
Interstitial lung disease; Nocturnal hypoxemia; Obstructive sleep apnea; Pulmonary hypertension; Sleep-disordered breathing;
D O I
10.1007/s11325-021-02555-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose Sleep disturbance is common in patients with advanced interstitial lung disease (ILD) often complicated by pulmonary hypertension (PH) and may contribute to poor quality of life. The etiology of sleep disturbance and the relationship between PH and sleep architecture in patients with ILD remains unknown. Methods We performed a retrospective cohort study comparing sleep architecture on polysomnography in patients with ILD with and without PH, defined as mean pulmonary artery pressure on right heart catheterization >= 20 mmHg. We tested the hypothesis that patients with ILD and PH would have increased wake time after sleep onset (WASO) compared to patients with ILD without PH using univariate analysis and multivariable linear regression. Results In our cohort of patients with ILD who underwent polysomnography (N = 49), patients with PH had lower total diffusion capacity for carbon monoxide (DLCO) (9.28 vs. 12.87 ml/min/mmHg, P = 0.04) and percent DLCO (39% vs. 53%, P = 0.03). On polysomnography, patients with PH had increased percentage of total sleep time with saturation < 90% (T90) (17% vs. 6%, P = 0.03), decreased N2 sleep (181 vs. 233 min, P = 0.03), decreased %N2 sleep (59% vs. 66%, P = 0.04), increased %N1 sleep (22% vs. 14%, P = 0.02), decreased sleep efficiency (62% vs. 72%, P = 0.03), and increased WASO (133 vs. 84 min, P = 0.01). In multivariable analysis, PH was associated with a 43-min increase in WASO (95% CI 6.2-80.2, P = 0.02). Conclusion Patients with ILD and PH have decreased total and %N2 sleep, increased %N1 sleep, decreased sleep efficiency, and increased WASO, likely indicating increased sleep fragmentation.
引用
收藏
页码:1711 / 1715
页数:5
相关论文
共 50 条
[21]   Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis [J].
Jessica L. Fairley ;
Dylan Hansen ;
Laura Ross ;
Susanna Proudman ;
Joanne Sahhar ;
Gene-Siew Ngian ;
Jennifer Walker ;
Lauren V. Host ;
Kathleen Morrisroe ;
Diane Apostolopoulous ;
Nava Ferdowsi ;
Michelle Wilson ;
Maryam Tabesh ;
Wendy Stevens ;
Mandana Nikpour .
Arthritis Research & Therapy, 25
[22]   Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis [J].
Fairley, Jessica L. ;
Hansen, Dylan ;
Ross, Laura ;
Proudman, Susanna ;
Sahhar, Joanne ;
Ngian, Gene-Siew ;
Walker, Jennifer ;
Host, Lauren, V ;
Morrisroe, Kathleen ;
Apostolopoulous, Diane ;
Ferdowsi, Nava ;
Wilson, Michelle ;
Tabesh, Maryam ;
Stevens, Wendy ;
Nikpour, Mandana .
ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[23]   Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics [J].
Haynes, Zachary A. ;
Chandel, Abhimanyu ;
King, Christopher S. .
CELLS, 2023, 12 (19)
[24]   Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the "HYPID" study [J].
Cottin, Vincent ;
Reynaud-Gaubert, Martine ;
Nunes, Hilario ;
Montani, David ;
Wallaert, Benoit ;
Camara, Boubou ;
Khouatra, Chahera ;
Israel-Biet, Dominique ;
Uzunhan, Yuerdagul ;
Gomez, Emmanuel ;
Marchand-Adam, Sylvain ;
Nieves, Ana ;
Jais, Xavier ;
Wemeau-Stervinou, Lidwine ;
Traclet, Julie ;
Launay, David ;
Dromer, Claire ;
Magnier, Romain ;
Prevot, Gregoire ;
Polazzi, Stephanie ;
Zeghmar, Sabrina ;
Schott, Anne-Marie ;
Humbert, Marc ;
Cordier, Jean-Francois .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[25]   Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease A Multidisciplinary Delphi Study [J].
Rahaghi, Franck F. ;
Kolaitis, Nicholas A. ;
Adegunsoye, Ayodeji ;
de Andrade, Joao A. ;
Flaherty, Kevin R. ;
Lancaster, Lisa H. ;
Lee, Joyce S. ;
Levine, Deborah J. ;
Preston, Ioana R. ;
Safdar, Zeenat ;
Saggar, Rajan ;
Sahay, Sandeep ;
Scholand, Mary Beth ;
Shlobin, Oksana A. ;
Zisman, David A. ;
Nathan, Steven D. .
CHEST, 2022, 162 (01) :145-155
[26]   Management of pulmonary hypertension resulting from interstitial lung disease [J].
Shapiro, S .
CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (05) :426-430
[27]   Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease [J].
Lawrence, Alexandra ;
Myall, Katherine Jane ;
Mukherjee, Bhashkar ;
Marino, Philip .
LIFE-BASEL, 2024, 14 (09)
[28]   Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease [J].
Melendres-Groves, Lana ;
Vazquez-Guillamet, Rodrigo ;
Dhillon, Gundeep .
CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) :156-162
[29]   Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment [J].
Behr, Juergen ;
Nathan, Steven D. .
CURRENT OPINION IN PULMONARY MEDICINE, 2021, 27 (05) :396-404
[30]   Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial [J].
Hoeper, Marius M. ;
Halank, Michael ;
Wilkens, Heinrike ;
Guenther, Andreas ;
Weimann, Gerrit ;
Gebert, Irmingard ;
Leuchte, Hanno H. ;
Behr, Juergen .
EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (04) :853-860